Studies have indicated that MYEOV is a key gene associated with acidosis markers, with elevated expression levels in pancreatic cancer (PC) tumor tissues compared to normal tissues, and this increased expression is closely related to poor clinical outcomes in patients with pancreatic cancer (53). This evidence concerns the gene MYEOV and pancreatic neoplasm.